mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.6 |